Albumin Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Albumin Market covers analysis By Product (Human Serum Albumin, Bovine Serum Albumin and Recombinant Albumin); Application(Therapeutics, Drug Formulation & Vaccines, Component of media and Other Applications), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00003986
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Albumin Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

MARKET OVERVIEW
:
The most ubiquitous protein in human blood and the key to controlling blood osmotic pressure. Albumin is soluble in water, precipitated by acid, and heat causes it to coagulate.

MARKET SCOPE

The "Albumin market to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of albumin market with detailed market segmentation by of Product, Application. The albumin market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in albumin market and offers key trends and opportunities in the market.
MARKET SEGMENTATION

  •  n the basis of product, the market is segmented into Human Serum Albumin, Bovine Serum Albumin and Recombinant Albumin.
  •  n the basis of application, the market is segmented into Therapeutics, Drug Formulation & Vaccines, and Component of media and Other Applications.

MARKET DYNAMICS
Drivers:

  •  The market is being driven by factors such as the high demand for albumin in R&D activities, the growth in non-therapeutic applications of albumin, the development of plant-based albumin, the rise in immunoglobulin production, and the rise in plasma collection.

Restraints

    The market growth is constrained by strict restrictions, restricted reimbursement, inappropriate usage, and side effects connected with albumin..

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the albumin market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The albumin market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting albumin market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the albumin market in these regions.

IMPACT OF COVID-19 ON AlBUMIN MARKET:
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. The global impacts of the COVID-19 are already starting to be felt, and will significantly affect the albumin market in 2021.Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

World Geography

Have a question?

Analyst

Mrinal

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the albumin market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The albumin market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting albumin market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the albumin market in these regions.

IMPACT OF COVID-19 ON AlBUMIN MARKET:
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. The global impacts of the COVID-19 are already starting to be felt, and will significantly affect the albumin market in 2021.Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the albumin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from albumin market are anticipated to have lucrative growth opportunities in the future with the rising demand for albumin market in the global market. Below mentioned is the list of few companies engaged in the albumin market.

The report also includes the profiles of key players in albumin market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •  Abbott
  •  Beckman Coulter, Inc
  •  Bio-Rad Laboratories, Inc.
  •  DiaSys Diagnostic Systems GmbH
  •  F. Hoffmann-La Roche Ltd
  •  Randox Laboratories Ltd.
  •  SEBIA
  •  TaiDoc Technology Corporation
  •  Tosoh Bioscience, Inc.
  •  Trinity Biotech Plc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Albumin Market - By Product
1.3.2 Albumin Market - By Application
1.3.3 Albumin Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ALBUMIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ALBUMIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ALBUMIN MARKET - GLOBAL MARKET ANALYSIS
6.1. ALBUMIN - GLOBAL MARKET OVERVIEW
6.2. ALBUMIN - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. ALBUMIN MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. HUMAN SERUM ALBUMIN
7.3.1. Overview
7.3.2. Human Serum Albumin Market Forecast and Analysis
7.4. BOVINE SERUM ALBUMIN
7.4.1. Overview
7.4.2. Bovine Serum Albumin Market Forecast and Analysis
7.5. RECOMBINANT ALBUMIN
7.5.1. Overview
7.5.2. Recombinant Albumin Market Forecast and Analysis
8. ALBUMIN MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. THERAPEUTICS
8.3.1. Overview
8.3.2. Therapeutics Market Forecast and Analysis
8.4. DRUG FORMULATION AND VACCINES
8.4.1. Overview
8.4.2. Drug Formulation and Vaccines Market Forecast and Analysis
8.5. COMPONENT OF MEDIA
8.5.1. Overview
8.5.2. Component of media Market Forecast and Analysis
8.6. OTHER APPLICATIONS.
8.6.1. Overview
8.6.2. Other Applications. Market Forecast and Analysis
9. ALBUMIN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Albumin Market Overview
9.1.2 North America Albumin Market Forecasts and Analysis
9.1.3 North America Albumin Market Forecasts and Analysis - By Product
9.1.4 North America Albumin Market Forecasts and Analysis - By Application
9.1.5 North America Albumin Market Forecasts and Analysis - By Countries
9.1.5.1 United States Albumin Market
9.1.5.1.1 United States Albumin Market by Product
9.1.5.1.2 United States Albumin Market by Application
9.1.5.2 Canada Albumin Market
9.1.5.2.1 Canada Albumin Market by Product
9.1.5.2.2 Canada Albumin Market by Application
9.1.5.3 Mexico Albumin Market
9.1.5.3.1 Mexico Albumin Market by Product
9.1.5.3.2 Mexico Albumin Market by Application
9.1.5.4 US Albumin Market
9.1.5.4.1 US Albumin Market by Product
9.1.5.4.2 US Albumin Market by Application
9.2. EUROPE
9.2.1 Europe Albumin Market Overview
9.2.2 Europe Albumin Market Forecasts and Analysis
9.2.3 Europe Albumin Market Forecasts and Analysis - By Product
9.2.4 Europe Albumin Market Forecasts and Analysis - By Application
9.2.5 Europe Albumin Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Albumin Market
9.2.5.1.1 Germany Albumin Market by Product
9.2.5.1.2 Germany Albumin Market by Application
9.2.5.2 France Albumin Market
9.2.5.2.1 France Albumin Market by Product
9.2.5.2.2 France Albumin Market by Application
9.2.5.3 Italy Albumin Market
9.2.5.3.1 Italy Albumin Market by Product
9.2.5.3.2 Italy Albumin Market by Application
9.2.5.4 Spain Albumin Market
9.2.5.4.1 Spain Albumin Market by Product
9.2.5.4.2 Spain Albumin Market by Application
9.2.5.5 United Kingdom Albumin Market
9.2.5.5.1 United Kingdom Albumin Market by Product
9.2.5.5.2 United Kingdom Albumin Market by Application
9.2.5.6 Rest of Europe Albumin Market
9.2.5.6.1 Rest of Europe Albumin Market by Product
9.2.5.6.2 Rest of Europe Albumin Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Albumin Market Overview
9.3.2 Asia-Pacific Albumin Market Forecasts and Analysis
9.3.3 Asia-Pacific Albumin Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Albumin Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Albumin Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Albumin Market
9.3.5.1.1 Australia Albumin Market by Product
9.3.5.1.2 Australia Albumin Market by Application
9.3.5.2 China Albumin Market
9.3.5.2.1 China Albumin Market by Product
9.3.5.2.2 China Albumin Market by Application
9.3.5.3 India Albumin Market
9.3.5.3.1 India Albumin Market by Product
9.3.5.3.2 India Albumin Market by Application
9.3.5.4 Japan Albumin Market
9.3.5.4.1 Japan Albumin Market by Product
9.3.5.4.2 Japan Albumin Market by Application
9.3.5.5 Rest of Asia-Pacific Albumin Market
9.3.5.5.1 Rest of Asia-Pacific Albumin Market by Product
9.3.5.5.2 Rest of Asia-Pacific Albumin Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Albumin Market Overview
9.4.2 Middle East and Africa Albumin Market Forecasts and Analysis
9.4.3 Middle East and Africa Albumin Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Albumin Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Albumin Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Albumin Market
9.4.5.1.1 South Africa Albumin Market by Product
9.4.5.1.2 South Africa Albumin Market by Application
9.4.5.2 Saudi Arabia Albumin Market
9.4.5.2.1 Saudi Arabia Albumin Market by Product
9.4.5.2.2 Saudi Arabia Albumin Market by Application
9.4.5.3 U.A.E Albumin Market
9.4.5.3.1 U.A.E Albumin Market by Product
9.4.5.3.2 U.A.E Albumin Market by Application
9.4.5.4 Rest of Middle East and Africa Albumin Market
9.4.5.4.1 Rest of Middle East and Africa Albumin Market by Product
9.4.5.4.2 Rest of Middle East and Africa Albumin Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Albumin Market Overview
9.5.2 South and Central America Albumin Market Forecasts and Analysis
9.5.3 South and Central America Albumin Market Forecasts and Analysis - By Product
9.5.4 South and Central America Albumin Market Forecasts and Analysis - By Application
9.5.5 South and Central America Albumin Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Albumin Market
9.5.5.1.1 Brazil Albumin Market by Product
9.5.5.1.2 Brazil Albumin Market by Application
9.5.5.2 Argentina Albumin Market
9.5.5.2.1 Argentina Albumin Market by Product
9.5.5.2.2 Argentina Albumin Market by Application
9.5.5.3 Rest of South and Central America Albumin Market
9.5.5.3.1 Rest of South and Central America Albumin Market by Product
9.5.5.3.2 Rest of South and Central America Albumin Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ALBUMIN MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ALBUMIN MARKET, KEY COMPANY PROFILES
12.1. BAXTER INTERNATIONAL INC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CHINA BIOLOGIC PRODUCTS HOLDINGS INC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CSL LIMITED
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GRIFOLS S.A
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK KGAA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. NOVOZYMES A/S
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. OCTAPHARMA AG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SHIRE PLC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. THERMO FISHER SCIENTIFIC INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. VENTRIA BIOSCIENCE
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS


The List of Companies

1. Baxter International Inc
2. China Biologic Products Holdings Inc
3. CSL Limited
4. Grifols S.A
5. Merck KGaA
6. Novozymes A/S
7. Octapharma AG
8. Shire Plc
9. Thermo Fisher Scientific Inc
10. Ventria Bioscience
11. Octapharma AG
12. HiMedia Laboratories
13. Mitsubishi Tanabe Pharma
14. Sigma-Aldrich Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..